BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership126.9%+3.82 pts vs. prior quarter
Institutions holding420+34 vs. prior quarter
Insider trades (recent)35 buys / 15 sellsNet buying
Short interest15.07% of floatDays to cover 8.7 · as of 30 Oct 2026
Short-sale volume share18.4%5-day average of daily volume

Short-sale volume as % of daily volume

5%16%27%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$16.88M (14 inflow days, 6 outflow days).

Net flow by order size, last 20 sessions

+$8.0MSuper+$8.9MBig+$818.7KMid−$2.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.2% of shares outstanding.

Largest holders

  • Janus Henderson Group plc12.24%
  • FMR9.42%
  • BlackRock7.99%
  • Perceptive Advisors LLC7.28%
  • Baker Bros. Advisors LP6.27%
  • Orbis Investment Management Limited5.47%
  • Vanguard Portfolio Management, LLC4.67%
  • Vanguard Capital Management, LLC4.40%

By investor type

  • Mutual Fund82.33%
  • Hedge Fund23.38%
  • VC/PE Fund9.44%
  • Public Company7.10%
  • Government Pension Fund1.43%
  • Private Company1.33%
  • Sovereign Wealth Fund1.25%
  • Endowment Fund0.30%

Reported short interest has risen from 13.30% to 15.07% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +317,883 9.4%
Franklin Resources Mutual Fund 2026/Q3 +255,231 2.1%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +211,127 0.8%
Emerald Advisers, LLC Mutual Fund 2026/Q3 +185,830 0.7%
Jane Street Group, LLC Private Company 2026/Q3 +80,442 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +578,437 4.8%
Invesco Ltd. Mutual Fund 2026/Q3 +511,820 1.9%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +342,615 1.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +297,387 3.9%
Polar Capital Holdings Plc Mutual Fund 2026/Q3 +279,131 1.0%
Westfield Capital Management Company, L.P. Mutual Fund 2026/Q3 +218,236 0.8%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +199,741 3.6%
FMR Mutual Fund 2026/Q3 +155,686 8.3%
State Street Global Advisors Mutual Fund 2026/Q3 +142,205 3.7%
American Century Investment Management Mutual Fund 2026/Q3 +109,061 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Jul 2026 Marcio De'Souza Chief Executive Officer Other Disposition -23,121 – 730
23 Jun 2026 Jill DeSimone Independent Director Derivative Exercise and Sale -11,600 $315.71 2,337
9 Jun 2026 William Young Independent Director Other Acquisition +1,371 – 1,371
9 Jun 2026 William Young Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Jeffrey Kindler Independent Director Other Acquisition +1,371 – 2,059
9 Jun 2026 Jeffrey Kindler Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Dean Mitchell Independent Chairperson Other Acquisition +1,371 – 1,371
9 Jun 2026 Dean Mitchell Independent Chairperson Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Gregory Norden Independent Director Other Acquisition +1,371 – 1,371
9 Jun 2026 Gregory Norden Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Merit Cudkowicz Independent Director Other Acquisition +1,371 – 1,371
9 Jun 2026 Merit Cudkowicz Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Stuart Arbuckle Independent Director Other Acquisition +1,371 – 2,059
9 Jun 2026 Stuart Arbuckle Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Jill DeSimone Independent Director Other Acquisition +1,371 – 1,371
9 Jun 2026 Jill DeSimone Independent Director Other Derivative Acquisition +648 $240.66 648
9 Jun 2026 Jeffrey Chodakewitz Independent Director Other Acquisition +1,371 – 1,371
9 Jun 2026 Jeffrey Chodakewitz Independent Director Other Derivative Acquisition +648 $240.66 648
13 May 2026 Alex Nemiroff General Counsel Other Acquisition +78 $167.94 6,798
13 May 2026 Marcio De'Souza Chief Executive Officer Other Acquisition +126 $167.94 23,851

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,207,692 15.1% 8.7
15 Oct 2026 3,921,934 14.0% 7.4
30 Sep 2026 4,188,193 15.0% 7.2
15 Sep 2026 3,795,697 13.6% 14.9
31 Aug 2026 3,740,751 13.4% 10.2
14 Aug 2026 3,714,692 13.3% 7.8

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top